Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia
Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia
About this item
Full title
Author / Creator
Publisher
New Delhi, India: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
New Delhi, India: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Background: Antipsychotic treatment-induced hyperprolactinemia is a highly distressing and disabling side effect for patients. The use of add-on aripiprazole has been identified as a possible treatment strategy in this situation. However, data on prolactin changes with add-on aripiprazole in a real-world naturalistic clinical setting from India are...
Alternative Titles
Full title
Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6a216a8b8be54259ab8c2f3d1803b1e1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6a216a8b8be54259ab8c2f3d1803b1e1
Other Identifiers
ISSN
0253-7176,0975-1564
E-ISSN
0975-1564
DOI
10.4103/IJPSYM.IJPSYM_147_17
